Date Posted: 02/22/2010 Size: 5.62MB Length: 00:12:17 Thought Leader: Daniel Garen, Chief Compliance Officer and Senior Counsel, Siemens Healthcare Sector, USAIn an exclusive interview with PharmaVOICE, Mr. Garen shares his expertise and insights on a variety of commercial compliance issues, including The Sunshine Act, Healthcare Reform, the Foreign Corrupt Practices Act (FCPA), and how companies can create a culture of compliance through proactivity. Mr. Garen is also the keynote speaker at the upcoming Marcus Evans’ Commercial Compliance for Pharmaceutical and Medical Device Companies Conference, April 12-13, Washington, D.C. For more information about the conference, please go to: http://www.marcusevansch.com/commericalcompliance.
Play Podcast
- Heather Reilly Powell – Regulatory Expert
- Training Seminar: Medical Education for Pharmaceutical Professionals: Information, May 6, 2008
- The State of Women in Healthcare
- The Benefits of a Proactive Compliance Program
- Will consumers trust the government more than pharma and medical device companies to compare treatment options ?
Tags: expertise, Featured, foreign, foreign-corrupt, keynote, keynote-speaker, medical-device, Podcasts, senior-counsel, thought-leader
Business Week – Drug Marketing
Business Week – Pharma Marketing
Cafe Pharma
Clinical Trials.gov
FDA on Twitter
Pharma Live
Pharma Voice